Bank of America Securities analyst Joanna Gajuk reiterated a Sell rating on Brookdale Senior Living (BKD – Research Report) yesterday and set a price target of $6.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Joanna Gajuk’s rating is based on a combination of factors that suggest Brookdale Senior Living may face challenges ahead. Despite a better-than-expected performance in the first quarter, the company’s cautious outlook for the rest of the year, coupled with plans for increased discounting to drive occupancy, raises concerns. While occupancy rates showed improvement, the need for discounting in a strong demand environment could indicate underlying issues.
Additionally, Brookdale’s plan to divest non-core assets and exit certain leases suggests a strategic shift that may not immediately benefit the company’s financials. The ongoing search for a CEO with operational expertise further highlights the need for strategic leadership. These factors contribute to the view that Brookdale is less favorably positioned compared to its peers to capitalize on industry trends, leading to the Sell rating.
Gajuk covers the Healthcare sector, focusing on stocks such as UnitedHealth, Chemed, and Addus Homecare. According to TipRanks, Gajuk has an average return of -1.0% and a 53.80% success rate on recommended stocks.